Literature DB >> 11089616

Viral dynamics in primary HIV-1 infection. Karolinska Institutet Primary HIV Infection Study Group.

S Lindbäck1, A C Karlsson, J Mittler, A Blaxhult, M Carlsson, G Briheim, A Sönnerborg, H Gaines.   

Abstract

OBJECTIVES: To study the natural course of viremia during primary HIV infection (PHI).
METHOD: Eight patients were followed from a median of 5 days from the onset of PHI illness. Plasma HIV-1 RNA levels were measured frequently and the results were fitted to mathematical models. HIV-1 RNA levels were also monitored in nine patients given two reverse transcriptase inhibitors and a protease inhibitor after a median of 7 days from the onset of PHI illness.
RESULTS: HIV-1 RNA appeared in the blood during the week preceding onset of PHI illness and increased rapidly during the first viremic phase, reaching a peak at a mean of 7 days after onset of illness. This was followed by a phase of rapidly decreasing levels of HIV-1 RNA to an average of 21 days after onset. Viral density continued to decline thereafter but at a 5- to 50-fold lower rate; a steady-state level was reached at a median of 2 months after onset of PHI. Peak viral density levels correlated significantly with levels measured between days 50 and 600. Initiation of antiretroviral treatment during PHI resulted in rapidly declining levels to below 50 copies/mL.
CONCLUSIONS: This study demonstrates the kinetic phases of viremia during PHI and indicates two new contributions to the natural history of HIV-1 infection: PHI peak levels correlate with steady-state levels and HIV-1 RNA declines biphasically; an initial rapid decay is usually followed by a slow decay, which is similar to the initial changes seen with antiviral treatment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11089616     DOI: 10.1097/00002030-200010200-00009

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  38 in total

1.  Probability of HIV transmission during acute infection in Rakai, Uganda.

Authors:  Steven D Pinkerton
Journal:  AIDS Behav       Date:  2007-12-07

2.  How many sexually-acquired HIV infections in the USA are due to acute-phase HIV transmission?

Authors:  Steven D Pinkerton
Journal:  AIDS       Date:  2007-07-31       Impact factor: 4.177

3.  Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection.

Authors:  Andrew C Young; Constantin T Yiannoutsos; Manu Hegde; Evelyn Lee; Julia Peterson; Rudy Walter; Richard W Price; Dieter J Meyerhoff; Serena Spudich
Journal:  Neurology       Date:  2014-09-26       Impact factor: 9.910

4.  Association of recent HIV infection and in-utero HIV-1 transmission.

Authors:  Taha E Taha; Maria M James; Donald R Hoover; Jin Sun; Oliver Laeyendecker; Caroline E Mullis; Johnstone J Kumwenda; Jairam R Lingappa; Bertran Auvert; Charles S Morrison; Lynne M Mofensen; Allan Taylor; Mary G Fowler; Newton I Kumenda; Susan H Eshleman
Journal:  AIDS       Date:  2011-07-17       Impact factor: 4.177

5.  The cost-effectiveness of expanded testing for primary HIV infection.

Authors:  Andrew Coco
Journal:  Ann Fam Med       Date:  2005 Sep-Oct       Impact factor: 5.166

6.  Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.

Authors:  Stephanie J Bissel; Julia Kofler; Julia Nyaundi; Michael Murphey-Corb; Stephen R Wisniewski; Clayton A Wiley
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-08       Impact factor: 4.147

7.  Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection.

Authors:  Gretja Schnell; Richard W Price; Ronald Swanstrom; Serena Spudich
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

8.  Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand.

Authors:  Merlin L Robb; Leigh A Eller; Hannah Kibuuka; Kathleen Rono; Lucas Maganga; Sorachai Nitayaphan; Eugene Kroon; Fred K Sawe; Samuel Sinei; Somchai Sriplienchan; Linda L Jagodzinski; Jennifer Malia; Mark Manak; Mark S de Souza; Sodsai Tovanabutra; Eric Sanders-Buell; Morgane Rolland; Julie Dorsey-Spitz; Michael A Eller; Mark Milazzo; Qun Li; Andrew Lewandowski; Hao Wu; Edith Swann; Robert J O'Connell; Sheila Peel; Peter Dawson; Jerome H Kim; Nelson L Michael
Journal:  N Engl J Med       Date:  2016-05-18       Impact factor: 91.245

Review 9.  HIV transmission.

Authors:  George M Shaw; Eric Hunter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

10.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Authors:  Jesus F Salazar-Gonzalez; Maria G Salazar; Brandon F Keele; Gerald H Learn; Elena E Giorgi; Hui Li; Julie M Decker; Shuyi Wang; Joshua Baalwa; Matthias H Kraus; Nicholas F Parrish; Katharina S Shaw; M Brad Guffey; Katharine J Bar; Katie L Davis; Christina Ochsenbauer-Jambor; John C Kappes; Michael S Saag; Myron S Cohen; Joseph Mulenga; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Martin Markowitz; Peter Hraber; Alan S Perelson; Tanmoy Bhattacharya; Barton F Haynes; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.